Search

Sergio Coffa

Examiner (ID: 9433, Phone: (571)270-3022 , Office: P/1675 )

Most Active Art Unit
1658
Art Unit(s)
1676, 1658, 1675, 1654
Total Applications
931
Issued Applications
452
Pending Applications
139
Abandoned Applications
357

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19809519 [patent_doc_number] => 12240890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Compositions and methods for treating and/or preventing pathogenic fungal infection and for maintenance of microbiome commensalism [patent_app_type] => utility [patent_app_number] => 16/611128 [patent_app_country] => US [patent_app_date] => 2018-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 16 [patent_no_of_words] => 22567 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611128 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/611128
Compositions and methods for treating and/or preventing pathogenic fungal infection and for maintenance of microbiome commensalism May 15, 2018 Issued
Array ( [id] => 13413189 [patent_doc_number] => 20180258137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-13 [patent_title] => CONTROL OF COPOLYMER COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 15/980478 [patent_app_country] => US [patent_app_date] => 2018-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3158 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15980478 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/980478
CONTROL OF COPOLYMER COMPOSITIONS May 14, 2018 Abandoned
Array ( [id] => 15866155 [patent_doc_number] => 20200140481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => PREPARATION OF BIOLOGICALLY ACTIVE COMPLEXES [patent_app_type] => utility [patent_app_number] => 16/612272 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4108 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612272 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/612272
PREPARATION OF BIOLOGICALLY ACTIVE COMPLEXES May 13, 2018 Abandoned
Array ( [id] => 17103215 [patent_doc_number] => 11123406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-21 [patent_title] => Rapid-acting insulin compositions [patent_app_type] => utility [patent_app_number] => 15/978329 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15970 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978329 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/978329
Rapid-acting insulin compositions May 13, 2018 Issued
Array ( [id] => 16206539 [patent_doc_number] => 20200239529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => NANOSTRUCTURED PROTEINS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/611102 [patent_app_country] => US [patent_app_date] => 2018-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32750 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611102 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/611102
NANOSTRUCTURED PROTEINS AND USES THEREOF May 6, 2018 Abandoned
Array ( [id] => 15589675 [patent_doc_number] => 20200071372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereof [patent_app_type] => utility [patent_app_number] => 16/610532 [patent_app_country] => US [patent_app_date] => 2018-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12788 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610532 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/610532
C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereof May 3, 2018 Pending
Array ( [id] => 15618829 [patent_doc_number] => 20200079819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-12 [patent_title] => Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker Patient [patent_app_type] => utility [patent_app_number] => 16/611172 [patent_app_country] => US [patent_app_date] => 2018-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7223 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611172 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/611172
Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker Patient May 3, 2018 Pending
Array ( [id] => 15678463 [patent_doc_number] => 20200093895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => STABLE INSULIN FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/610826 [patent_app_country] => US [patent_app_date] => 2018-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12300 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610826 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/610826
STABLE INSULIN FORMULATIONS May 2, 2018 Pending
Array ( [id] => 16053237 [patent_doc_number] => 20200188473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => COMBINATION THERAPY FOR CANCER [patent_app_type] => utility [patent_app_number] => 16/609386 [patent_app_country] => US [patent_app_date] => 2018-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16085 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609386 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/609386
COMBINATION THERAPY FOR CANCER Apr 30, 2018 Abandoned
Array ( [id] => 13537211 [patent_doc_number] => 20180320152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => MODIFIED SULFAMIDASE AND PRODUCTION THEREOF [patent_app_type] => utility [patent_app_number] => 15/965597 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17500 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965597 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/965597
MODIFIED SULFAMIDASE AND PRODUCTION THEREOF Apr 26, 2018 Abandoned
Array ( [id] => 18286363 [patent_doc_number] => 20230101835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => MODIFIED COMPLEMENT PROTEINS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/608732 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33122 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608732 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/608732
Modified complement proteins and uses thereof Apr 24, 2018 Issued
Array ( [id] => 13372399 [patent_doc_number] => 20180237740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => DEFINED THREE DIMENSIONAL MICROENVIRONMENT FOR CELL CULTURE [patent_app_type] => utility [patent_app_number] => 15/953055 [patent_app_country] => US [patent_app_date] => 2018-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12313 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15953055 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/953055
Defined three dimensional microenvironment for cell culture Apr 12, 2018 Issued
Array ( [id] => 15493303 [patent_doc_number] => 20200046840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => PEPTIDE FOR CYTOSOLIC DELIVERY [patent_app_type] => utility [patent_app_number] => 16/496405 [patent_app_country] => US [patent_app_date] => 2018-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8614 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496405 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/496405
Peptide for cytosolic delivery Mar 21, 2018 Issued
Array ( [id] => 15407987 [patent_doc_number] => 20200024315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => ANTIMICROBIAL PEPTIDES AND METHODS OF TREATING GRAM-NEGATIVE PATHOGENS [patent_app_type] => utility [patent_app_number] => 16/495793 [patent_app_country] => US [patent_app_date] => 2018-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495793 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/495793
ANTIMICROBIAL PEPTIDES AND METHODS OF TREATING GRAM-NEGATIVE PATHOGENS Mar 19, 2018 Abandoned
Array ( [id] => 13444085 [patent_doc_number] => 20180273585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => Medical Use [patent_app_type] => utility [patent_app_number] => 15/924669 [patent_app_country] => US [patent_app_date] => 2018-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13409 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15924669 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/924669
Medical Use Mar 18, 2018 Abandoned
Array ( [id] => 16295489 [patent_doc_number] => 20200281212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => A SYNERGISTIC COMPOSITION OF A NEMATICIDE [patent_app_type] => utility [patent_app_number] => 16/495008 [patent_app_country] => US [patent_app_date] => 2018-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1999 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495008 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/495008
Synergistic composition of a nematicide Mar 16, 2018 Issued
Array ( [id] => 17604027 [patent_doc_number] => 11332498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Ligands for integrin aVb8, synthesis and uses thereof [patent_app_type] => utility [patent_app_number] => 16/494467 [patent_app_country] => US [patent_app_date] => 2018-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14073 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494467 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/494467
Ligands for integrin aVb8, synthesis and uses thereof Mar 15, 2018 Issued
Array ( [id] => 15342813 [patent_doc_number] => 20200009298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => A HYDROGEL COMPOSITE [patent_app_type] => utility [patent_app_number] => 16/490034 [patent_app_country] => US [patent_app_date] => 2018-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16125 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490034 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/490034
A HYDROGEL COMPOSITE Feb 28, 2018 Abandoned
Array ( [id] => 15394017 [patent_doc_number] => 10537645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-21 [patent_title] => Protein-polymer-drug conjugates [patent_app_type] => utility [patent_app_number] => 15/902540 [patent_app_country] => US [patent_app_date] => 2018-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 45658 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15902540 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/902540
Protein-polymer-drug conjugates Feb 21, 2018 Issued
Array ( [id] => 15267431 [patent_doc_number] => 20190382449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => UNIVERSAL ANTIVENOM [patent_app_type] => utility [patent_app_number] => 16/486639 [patent_app_country] => US [patent_app_date] => 2018-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486639 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/486639
Universal antivenom Feb 15, 2018 Issued
Menu